NCAPD3 and sarcoma: The high expression of NCAPD2, NCAPG, NCAPH, NCAPD3, and NCAPH2 were all correlated with the relapse-free survival of sarcoma patients, HR = 2.76 (p = 3.3e-05), 2.72 (p = 0.0012), 2.71 (p = 0.0026), 1.87 (p = 0.01) and 2.08 (p = 0.029) respectively (Figure 5B).